Hypertension, dyslipidemia, and insulin resistance in the spontaneously hypertensive rat (SHR) can be alleviated by rescuing CD36 fatty acid translocase. The present study investigated whether transgenic rescue of CD36 in SHR could affect mitochondrial function and activity of selected metabolic enzymes in the heart. These analyses were conducted on ventricular preparations derived from SHR and from transgenic strain SHR-Cd36 that expresses a functional wild-type CD36. Our respirometric measurements revealed that mitochondria isolated from the left ventricles exhibited two times higher respiratory activity than those isolated from the right ventricles. Whereas, we did not observe any significant changes in functioning of the mitochondrial respiratory system between both rat strains, enzyme activities of total hexokinase, and both mitochondrial and total malate dehydrogenase were markedly decreased in the left ventricles of transgenic rats, compared to SHR. We also detected downregulated expression of the succinate dehydrogenase subunit SdhB (complex II) and 70 kDa peroxisomal membrane protein in the left ventricles of SHR-Cd36. These data indicate that CD36 may affect in a unique fashion metabolic substrate flexibility of the left and right ventricles.

Department of Physiology Faculty of Science Charles University Prague Czech Republic

Institute of Physiology of the Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Pflugers Arch. 2013 Oct;465(10):1477-86 PubMed

Cardiology. 2015;130(4):211-20 PubMed

Mol Cell Biol. 2008 Jan;28(2):718-31 PubMed

J Proteomics. 2016 Aug 11;145:177-86 PubMed

J Biol Chem. 1999 Apr 23;274(17):11968-76 PubMed

Cardiovasc Pathol. 2014 Mar-Apr;23(2):101-6 PubMed

Jpn Circ J. 1963 Mar;27:282-93 PubMed

Lancet. 2001 Mar 3;357(9257):686-7 PubMed

Cell Physiol Biochem. 2014;33(2):310-20 PubMed

Arch Cardiovasc Dis. 2017 Oct;110(10):562-571 PubMed

Arch Biochem Biophys. 2007 Nov 15;467(2):234-8 PubMed

PPAR Res. 2015;2015:271983 PubMed

Biochim Biophys Acta. 2016 Oct;1861(10):1442-9 PubMed

Cardiovasc Res. 1995 Aug;30(2):205-11 PubMed

Am J Hypertens. 2000 Oct;13(10):1074-81 PubMed

Physiol Res. 2003;52(6):681-8 PubMed

J Card Fail. 2017 Mar;23(3):240-251 PubMed

Int J Mol Med. 1998 Apr;1(4):709-16 PubMed

Circulation. 2016 Aug 9;134(6):441-50 PubMed

Microvasc Res. 2014 Sep;95:131-42 PubMed

J Am Coll Cardiol. 1992 Jun;19(7):1550-8 PubMed

Nat Genet. 2001 Feb;27(2):156-8 PubMed

Nat Genet. 1999 Jan;21(1):76-83 PubMed

Clin Exp Pharmacol Physiol. 2002 Apr;29(4):339-45 PubMed

Biochimie. 2017 May;136:21-26 PubMed

Int J Mol Med. 2006 Jul;18(1):177-86 PubMed

Physiol Res. 2016 Dec 22;65(Supplementum 5):S601-S609 PubMed

Nat Methods. 2012 Jun 28;9(7):676-82 PubMed

Cardiology. 1993;83(3):160-4 PubMed

Mol Cell Biochem. 2003 Jan;242(1-2):89-99 PubMed

Cardiovasc Res. 2007 Sep 1;75(4):770-81 PubMed

Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1425-36 PubMed

J Clin Invest. 2002 May;109(10):1381-9 PubMed

Biochem Soc Trans. 2005 Feb;33(Pt 1):311-5 PubMed

J Biol Chem. 2004 Aug 27;279(35):36235-41 PubMed

Proteomics. 2006 Mar;6(6):1948-56 PubMed

Biochim Biophys Acta. 2011 Jul;1813(7):1360-72 PubMed

Nat Rev Cardiol. 2017 Apr;14(4):238-250 PubMed

J Cardiovasc Pharmacol. 2010 Aug;56(2):130-40 PubMed

J Proteome Res. 2009 May;8(5):2463-75 PubMed

Nat Genet. 2008 Aug;40(8):952-4 PubMed

Oncogene. 2017 Jul 6;36(27):3915-3924 PubMed

Thromb Haemost. 2015 Mar;113(3):452-63 PubMed

J Hypertens. 2002 Feb;20(2):323-31 PubMed

Physiol Genomics. 2012 Feb 1;44(2):173-82 PubMed

PLoS One. 2012;7(10):e47167 PubMed

Proteomics. 2008 Jun;8(12):2556-72 PubMed

Trends Cardiovasc Med. 2003 May;13(4):136-41 PubMed

J Immunol. 2014 Mar 1;192(5):1997-2006 PubMed

Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1561-7 PubMed

Cardiovasc Res. 2011 Aug 1;91(3):382-91 PubMed

Protein profiling of SH-SY5Y neuroblastoma cells: The effect of rhein